Page last updated: 2024-09-03

gefitinib and Cardiomyopathies, Primary

gefitinib has been researched along with Cardiomyopathies, Primary in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akhtar, MJ; Ali, Z; Dewangan, RP; Khan, AA; Pasha, S; Siddiqui, AA; Yar, MS	1
Naito, T; Omori, S; Oyakawa, T; Takahashi, T	1

Other Studies

2 other study(ies) available for gefitinib and Cardiomyopathies, Primary

Article	Year
Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors. European journal of medicinal chemistry, 2017, Jan-27, Volume: 126 Topics: Animals; Antineoplastic Agents; Benzimidazoles; Cardiomyopathies; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Liver; Molecular Docking Simulation; Phosphorylation; Protein Domains; Protein Kinase Inhibitors; Quantitative Structure-Activity Relationship; Rats; Receptor, ErbB-2	2017
Gefitinib-Induced Cardiomyopathy in Epidermal Growth Receptor-Mutated NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2018, Volume: 13, Issue:10 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cardiomyopathies; Female; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Mutation	2018

Article

Year

Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors.

European journal of medicinal chemistry, 2017, Jan-27, Volume: 126

Topics: Animals; Antineoplastic Agents; Benzimidazoles; Cardiomyopathies; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Liver; Molecular Docking Simulation; Phosphorylation; Protein Domains; Protein Kinase Inhibitors; Quantitative Structure-Activity Relationship; Rats; Receptor, ErbB-2

2017

Gefitinib-Induced Cardiomyopathy in Epidermal Growth Receptor-Mutated NSCLC.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2018, Volume: 13, Issue:10

Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cardiomyopathies; Female; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Mutation

2018